Not Yet Recruiting OBSERVATIONAL NCT07279298

Effectiveness of Immunization in Preventing Severe Acute Respiratory Infection RSV

Effectiveness of Immunization in Preventing Severe Acute Respiratory Infection Associated With Respiratory Syncytial Virus-RSV- in Infants Under 6 Months of Age in Bogotá: a Case-control Study With a Negative Test Design

Sponsor: Bogotá District Health Secretariat

Conditions Bronchiolitis, Viral Respiratory Syncytial Virus Infections Severe Acute Respiratory Infection Viral Respiratory Tract Infection

Interventions RSVpreF vaccine (Abrysvo) and Nirsevimab (Beyfortus) or unexposed

Updated 1 time since 2026 Last updated: Dec 1, 2025 Started: Feb 1, 2026 Primary completion: Dec 31, 2026 Completion: Jul 31, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT07279298, this observational or N/A phase trial focuses on Bronchiolitis, Viral and Respiratory Syncytial Virus Infections and remains actively recruiting participants. Sponsored by Bogotá District Health Secretariat, it has been updated 1 time since 2026, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

1 version recorded

Not Yet Recruiting [monthly]

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bogotá District Health Secretariat

Data source: Bogotá District Health Secretariat

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.